It has been demonstrated how inflammation affects cognitive function and brain structure, through biomarkers such as neurofilament light chain (NfL) and the N-terminal propeptide of type 1 procollagen (P1NP), which show a correlation with the severity of symptoms and cognitive decline in patients with mood disorders.79 This evidence concerns the gene NEFL and mood disorder.